Literature DB >> 11331884

Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.

H Miao1, B R Wei, D M Peehl, Q Li, T Alexandrou, J R Schelling, J S Rhim, J R Sedor, E Burnett, B Wang.   

Abstract

Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation. However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation or to transform rodent fibroblasts, indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331884     DOI: 10.1038/35074604

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  117 in total

1.  Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells.

Authors:  Ken-Ichiro Nagashima; Akira Endo; Hisakazu Ogita; Akiko Kawana; Akiko Yamagishi; Akira Kitabatake; Michiyuki Matsuda; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

Review 2.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

3.  EphB6 crosslinking results in costimulation of T cells.

Authors:  Hongyu Luo; Guang Yu; Yulian Wu; Jiangping Wu
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 4.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

5.  An Eph receptor sperm-sensing control mechanism for oocyte meiotic maturation in Caenorhabditis elegans.

Authors:  Michael A Miller; Paul J Ruest; Mary Kosinski; Steven K Hanks; David Greenstein
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

6.  The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.

Authors:  G Radziwill; R A Erdmann; U Margelisch; K Moelling
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  Xtalk: a path-based approach for identifying crosstalk between signaling pathways.

Authors:  Allison N Tegge; Nicholas Sharp; T M Murali
Journal:  Bioinformatics       Date:  2015-09-23       Impact factor: 6.937

Review 8.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  The L1 cell adhesion molecule is essential for topographic mapping of retinal axons.

Authors:  Galina P Demyanenko; Patricia F Maness
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

10.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.